| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
NUOVI MARCATORI ANGIOGENICI E IMMUNOMODULATORI NEL MELANOMA AVANZATO |
NA |
in corso |
MELANOMA |
- SC Medicina di Laboratorio |
|
A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER, GLOBAL STUDY OF PUXITATUG SAMROTECAN (AZD8205) MONOTHERAPY VERSUS PHYSICIAN’S CHOICE OF CHEMOTHERAPY IN PARTICIPANTS WITH B7-H4-SELECTED ADVANCED/METASTATIC ENDOMETRIAL CANCER WHO PROGRESSED ON OR AFTER PLATINUM-BASED CHEMOTHERAPY AND ANTI-PD-1/ANTI-PD-L1 THERAPY (AZD8205, D6900C00003, GOG-3110, ENGOT-en28) |
III |
in corso |
CANCRO ENDOMETRIALE AVANZATO/METASTATICO |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
Prostate Radiotherapy: IRIS vs MLC – matching Use in SBRT |
NA |
in corso |
CARCINOMA DELLA PROSTATA |
- SC Radioterapia |
|
A PHASE 1A/1B STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND PRELIMINARY ANTITUMOR ACTIVITY OF BG-75202, ALONE AND IN COMBINATION WITH OTHER AGENTS IN PATIENTS WITH ADVANCED SOLID TUMORS |
I/II |
in corso |
TUMORI SOLIDI |
- SC Sperimentazioni Cliniche |
|
A PHASE 2 STUDY OF ACR-368 THERAPY IN SUBJECTS WITH ENDOMETRIAL CANCER |
II |
in corso |
CANCRO ENDOMETRIALE |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
